The Pharmacy Times® Retail Clinical Role section is a comprehensive resource for clinical news and expert insights on issues pertaining to retail, community, and independent pharmacists.
July 4th 2025
Stroke, myocardial infarction, and all-cause death were included in the composite of adverse cardiovascular events.
FDA Issues New Labeling Changes Clarifying Safety of Testosterone Products Following Clinical Trials
March 4th 2025The FDA is issuing new changes to labels on testosterone products, clarifying that there are no increases in major cardiac events among men with hypogonadism but noting an increase in blood pressure with the use of such products.
Read More